George Magrath
Chief Executive Officer bij OCUPHIRE PHARMA, INC.
Vermogen: 854 250 $ op 31-03-2024
Profiel
George Magrath is currently the Chief Executive Officer & Director at Ocuphire Pharma, Inc. He was previously the Chief Executive Officer & Director at Lexitas Pharma Services, Inc. from 2021 to 2023.
Prior to that, he worked as an Analyst at Edison Investment Research, Inc. Dr. Magrath holds a doctorate degree from the Medical University of South Carolina, an MBA from The Citadel, The Military College of South Carolina, an undergraduate degree from Clemson University, and a graduate degree from The Johns Hopkins University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
1.71% | 18-03-2024 | 425 000 ( 1.71% ) | 854 250 $ | 31-03-2024 |
Actieve functies van George Magrath
| Bedrijven | Functie | Begin |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Chief Executive Officer | 01-11-2023 |
Eerdere bekende functies van George Magrath
| Bedrijven | Functie | Einde |
|---|---|---|
Lexitas Pharma Services , Inc.
 Lexitas Pharma Services , Inc. Medical/Nursing ServicesHealth Services Lexitas Pharma Services, Inc. is a product development organization that specializes in delivering life-changing ophthalmic treatments to patients. The company is based in Durham, NC and was founded in 2011 by Saiid Davari, Joanna Williams, Chad Ice, Chris Brown. The company's team of skilled specialists, relationship builders, and ophthalmic experts have a wealth of expertise gained from years of running successful eye care studies. The company offers personalized services and end-to-end expert guidance to optimize study execution and design programs around specific study requirements. The CEO is George Magrath. | Chief Executive Officer | 30-09-2023 |
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | - |
Opleiding van George Magrath
| Medical University of South Carolina | Doctorate Degree |
| The Citadel, The Military College of South Carolina | Masters Business Admin |
| Clemson University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
| Ocuphire Pharma, Inc. | |
Lexitas Pharma Services , Inc.
Lexitas Pharma Services , Inc. Medical/Nursing ServicesHealth Services Lexitas Pharma Services, Inc. is a product development organization that specializes in delivering life-changing ophthalmic treatments to patients. The company is based in Durham, NC and was founded in 2011 by Saiid Davari, Joanna Williams, Chad Ice, Chris Brown. The company's team of skilled specialists, relationship builders, and ophthalmic experts have a wealth of expertise gained from years of running successful eye care studies. The company offers personalized services and end-to-end expert guidance to optimize study execution and design programs around specific study requirements. The CEO is George Magrath. | Health Services |
